Patients with HIV infection and mental illness: A study of clinical identification

Community Mental Health Journal

Volumn 39, Issue 6, 2003, Pages 523-533

  Douglas, Jae P ^a   Perrin, Nancy A ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

Detection; HIV; Mental illness

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL FUNCTION; MENTAL HEALTH SERVICE; POPULATION RESEARCH; PSYCHIATRIC DIAGNOSIS; QUESTIONNAIRE; UNITED STATES; COMPARATIVE STUDY; MEDICAL AUDIT;

FEMALE; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; MALE; MEDICAL AUDIT; MENTAL DISORDERS; OREGON;

EID: 1442351626     PISSN: 00103853     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:COMH.0000003013.68232.12     Document Type: Article

References (34)

1. Brazier, J. E., Harper, R., Jones, N. M., O'Cathain, A., Thomas, K. J., Usherwood, T., & Westlake, L. (1992). Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ, (305), 160-164.
2. Brown E.J., Jemmott L.S. (2000). HIV among people with mental illness: contributing factors, prevention needs, barriers, and strategies. Journal of Psychosocial Nursing & Mental Health Services, 38(4), 14-19.
3. Carey M.P., Carey K.B., Maisto S.A., Gordon C.M., Vanable P.A. (2001). Prevalence and correlates of sexual activity and HIV-related risk behavior among psychiatric outpatients. Journal of Consulting & Clinical Psychology, 69(5), 846-50.
4. Carey, M., & Cournos, F. (1997). HIV and AIDS among the severely mentally ill: Introduction to the special series. Clinical Psychology Review, 17(3), 241-245.
5. Chamberlain, D., Cole, N. (1999). The Portland EMA Housing Plan (Needs Assessment). Portland, OR. Multnomah County Health Department, Portland, OR.
6. Cournos, F., McKinnon, K. (1997). HIV seroprevalence among people with severe mental illness in the United States: A critical review. Clinical Psychology Review, 17(3), 259-269.
7. Davidson S., Judd F., Jolley D., Hocking B., Thompson S., Hyland B. (2001). Risk factors for HIV/ AIDS and hepatitis C among the chronic mentally ill. Australian & New Zealand Journal of Psychiatry, 35(2), 203-239.
8. Deeks, S. G., Smith, M., Kolodniy, M., & Kahn, J. O. (1997). HIV-1 protease inhibitors: A review for clinicians. JAMA, 276, 146-154.
9. Derogatis, L. R. (1994). SCL-90R Administration, Scoring and Procedures Manual. (3rd ed.). Minneapolis, MN: Leonard R. Derogatis and National Computer Systems, Inc.
10. Derogatis, L.R. & DellaPietra, L. (1994). The use of psychological testing for treatment planning and outcome assessment. In M. Maruish (ed.), Psychological tests in screening for psychiatric disorder. Hillsdale, NJ: Lawrence Erlbaum, pp.22-54.
11. Derogatis, L., Rickels, K., Rock, A. (1976). The SCL-90 and the MMPI: a step in the validation of a new self-report. Br J Psychiatry, Mar (128), 280-289.
12. Douglas, J. & Perrin, N. (2002). Service Integration for Clients with HIV Infection and Mental Illness: Does It Predict Improved Outcomes? Paper presentation at the Oregon Association of Nurses in AIDS Care, Portland, OR.
13. Fink, R., Win, H., Mesches, D., Lewin, D., Hermele, S., Tarolli, S., Jaeger, M. (1999). Primary care physician identification of emotional disorders in two organized medical group practices. Paper presented at the 10th Annual Symposium on Health Sciences Research in New York, NY.
14. Grigg, B., Brooks, R.G., Lieb, S., Grigg, M. (2001). Coding Changes and Apparent HIV/AIDS Mortality Trends in Florida, 1999. JAMA, 286(15), 1839.
15. Harmon, R. (1998). The HIV Case Management Partnership Project, Progress Report. Portland, OR: Oregon Health Sciences University.
16. Ho, D. D. (1996). Therapy of HIV infections: Problems and prospects. Bulletin of the New York Academy of Medicine, 73, 37-45.
17. Horowitz, M., Rosenberg, S., Baer, B., Ureno, G., Villasenor, V. (1988). Inventory of Interpersonal Problems: Psychometric properties and clinical applications. Journal of Consulting and Clinical Psychology, (56)6, 885-892.
18. Kelly, J. (1997). HIV risk reduction interventions, for persons with severe mental illness. Clinical Psychology Review, 17(3), 293-309.
19. Loveless, M. (1999). The Combined HIV, STD and TB Annual Report. Portland, OR: Portland Oregon Health Division.
20. McKinnon, K., Carey, M., Cournos, F. (1997). Research on HIV, AIDS, and severe mental illness: Recommendations from the NIMH National Conference. Clinical Psychology Review, 17(3), 327-331.
21. Mehr, J. 2001. Introduction to the special issue: Overview of MISA dual diagnosis and treatment. Psychiatric Rehabilitation Skills, 5(1), 22-28.
22. Moore, RD, Chaisson, RE, (1999). Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS, 13(14), 1933-1942.
23. Morbidity and Mortality Weekly Report. (1999). Guidelines for National Human Immunodeficiency Virus Case Surveillance, Including Monitoring for Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome. Recommendations and Reports. (Vol. 48, No. RR 13, 1-28. December 10, 1999).
24. Morbidity and Mortality Weekly Report. (2002). Guidelines for Using Antiretroviral Agents Among HIV-Infected Adults and Adolescents, Recommendations of the Panel on Clinical Practices for Treatment of HIV. (Vol. 51, No. RR-7, May 17, 1999).
25. Ormel, B., Tiemens, J., Simon, G. (1996) Occurrence, recognition, and outcome of psychological disorders in primary care. American Journal of Psychiatry, 153(5), 636-644.
26. Otto-Salaj, L.L., Kelly J.A., Stevenson L.Y., Hoffmann R., Kalichman S.C. (2001). Outcomes of a randomized small-group HIV prevention intervention trial for people with serious mental illness. Community Mental Health Journal, 37(2), 123-44.
27. Pinkerton SD., Johnson-Masotti AP, Otto-Salaj LL, Stevenson LY, Hoffmann RG. (2001). Cost-effectiveness of an HIV prevention intervention for mentally ill adults. Mental Health Services Research, 3(1), 45-55.
28. RMID. (1994). Guidelines for Project Coordinators. Portland, OR: The Center for Health Research.
29. Rosenberg S.D., Trumbetta S.L., Mueser K.T., Goodman L.A., Osher F.C., Vidaver R.M., Metzger D.S. (2001). Determinants of risk behavior for human immunodeficiency virus/acquired immunodeficiency syndrome in people with severe mental illness. Comprehensive Psychiatry, 42(4), 263-71.
30. Spitzer, R., Kroenke K., Williams J.B. (1999). Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA, 282(18), 1737-44.
31. Stall, R., Purcell, D.W. (2000). Intertwining epidemics: A review of research on substance use among men who have sex with men and its connection to the AIDS epidemic. AIDS & Behavior, 4(2), 181-192.
32. Torrey, W.C., Drake, R.E., Cohen, M., Fox, L.B., Lynde, D., Gorman, P., Wyzik, P. (2002). The challenge of implementing and sustaining integrated dual disorders treatment programs. Community Mental Health Journal, 38(6), 507-521.
33. Ware JE, S. C. (1992). The MOS 36-Item Short-Form Health Survey. Med Care, 30(6), 473-83.
34. Whitman, S., Murphy, J. Cohen, M. Sherer, R. (2000). Marked Declines in Human Immunodeficiency Virus-Related Mortality in Chicago in Women, African Americans Hispanics, Young Adults, and Injection Drug Users, From 1995 Through 1997. Archives of Internal Medicine, 160(3), 365-369.